-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
The aggregate amount of income or expense from ancillary business-related activities (that is to say, excluding major activities considered part of the normal operations of the business).
-
Summary
-
Context Therapeutics Inc. quarterly/annual Nonoperating Income (Expense) history and growth rate from Q3 2020 to Q2 2024.
- Context Therapeutics Inc. Nonoperating Income (Expense) for the quarter ending June 30, 2024 was -$6.11K, a 50.1% increase year-over-year.
- Context Therapeutics Inc. Nonoperating Income (Expense) for the twelve months ending June 30, 2024 was -$48.8K, a 373% decline year-over-year.
- Context Therapeutics Inc. annual Nonoperating Income (Expense) for 2023 was -$55.6K, a 2673% decline from 2022.
- Context Therapeutics Inc. annual Nonoperating Income (Expense) for 2022 was -$2K, a 102% decline from 2021.
- Context Therapeutics Inc. annual Nonoperating Income (Expense) for 2021 was $124K.
Nonoperating Income (Expense), Trailing 12 Months (USD)
Nonoperating Income (Expense), Quarterly (USD)
Nonoperating Income (Expense), YoY Quarterly Growth (%)